These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9634552)

  • 1. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.
    Gainetdinov RR; Fumagalli F; Jones SR; Caron MG
    J Neurochem; 1997 Sep; 69(3):1322-5. PubMed ID: 9282960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
    Zhu JP; Xu W; Angulo JA
    Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
    Xie T; McCann UD; Kim S; Yuan J; Ricaurte GA
    J Neurosci; 2000 Oct; 20(20):7838-45. PubMed ID: 11027249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
    Angulo JA; Angulo N; Yu J
    Ann N Y Acad Sci; 2004 Oct; 1025():171-80. PubMed ID: 15542715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
    Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity.
    Guilarte TR; Nihei MK; McGlothan JL; Howard AS
    Neuroscience; 2003; 122(2):499-513. PubMed ID: 14614914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y; Martin JL; Black MD; Ali SF
    Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.
    Fumagalli F; Gainetdinov RR; Wang YM; Valenzano KJ; Miller GW; Caron MG
    J Neurosci; 1999 Apr; 19(7):2424-31. PubMed ID: 10087057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies.
    Hirata H; Cadet JL
    J Neurochem; 1997 Aug; 69(2):780-90. PubMed ID: 9231739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.
    Thomas DM; Angoa Pérez M; Francescutti-Verbeem DM; Shah MM; Kuhn DM
    J Neurochem; 2010 Nov; 115(3):595-605. PubMed ID: 20722968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.
    Cass WA
    J Neurosci; 1996 Dec; 16(24):8132-9. PubMed ID: 8987838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.